Evercore ISI Group analyst Glenn Schorr maintains Morgan Stanley (NYSE:MS) with a Outperform and raises the price target from $90 to $106.
Jefferies Initiates Coverage On Madrigal Pharmaceuticals with Buy Rating, Announces Price Target of $151
Jefferies analyst Akash Tewari initiates coverage on Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Buy rating and announces Price Target of $151.